- AirPROM legacy – Check out the booklet
- The AirPROM project ended in May 2016, with a public event organised by EFA at the European Parliament, hosted by MEP David Borrelli. However the work does not finish when a project ends, especially w ...
- U-BIOPRED's role on patient involvement
- The Innovative Medicines Initiative (IMI) has published an interview with Professor Peter Sterk, coordinator of U-BIOPRED, one of the first projects launched by the IMI in 2009. According to Sterk, ...
- Chronic diseases in Europe: the Commission is urged to act
- EFA, the European Chronic Diseases Alliance (ECDA) and other public health organisations have sent an open letter to the European Commission urging them to act on chronic diseases. Chronic diseases ...
- The European Commission advances on “may contain” allergen labelling
- EFA brought to a European Commission workshop on precautionary labelling the patients perspective to abolish “may contain” mentions. With 17 million Europeans affected by food allergies, allergen info ...
- European Medicines Agency celebrates 10 years of collaboration with patients
- Our continuous input into the information, evaluation and safety and development policies of medicines in Europe is an achievement that we celebrate, especially after the renewal of EFA membership to ...
- EFA President moderates debate on care and research at EAACI Congress
- On the 13th of June, EFA President Mikaela Odemyr co-moderated a debate at a high-level policy meeting on the challenges and opportunities the European Union has to address allergy and asthma. This me ...
- EFA brings the patients’ perspective to the Medicines for Europe event
- On the 9th of June, EFA Senior EU Policy Adviser and Deputy Director Roberta Savli took part in a panel discussion on so-called value-added medicines organised in the framework of the Joint 22nd Medic ...
- European Patient Charter presented
- In the framework of the Patient Empowerment campaign, the European Patients’ Forum (EPF) has launched the European Patient Charter and a Roadmap for patient empowerment. EFA, as full Member and Board ...
- EU conclusions to make more balanced pharmaceutical systems
- On the 17th of June, the Council of the European Union issued conclusions on strengthening the balance in the pharmaceutical systems in the EU and its Member States. The Council recognises the importa ...
- EFA statement on value and pricing of innovative medicines
- EFA shares the European Patients’ Forum (EPF) view that health is a fundamental right for everyone and therefore medicines, which allow for this right to be fully enjoyed by all people, should not be ...
- Treat the person, not the disease – Outcomes of the Personalised Medicine Conference
- Personalised medicine is seen as part of a wider shift from disease-centred to person-centred healthcare, from one-size-fits-all, to individualized treatment and prevention. “To realise this shift, pa ...
- EFA calls for more and better public funding for patients groups
- On the 30th of June, the Committee on Budget of the European Parliament voted an own-initiative report on public funding for non-profit organisations. EFA, the European Patients’ Forum (EPF) and other ...
- How to invest on health to improve patient access to care?
- With 18 million patients declaring unmet needs on healthcare access (3.6% of the EU population), the European Commission Expert Panel on Effective Ways of Investing in Health, an independent commissio ...
- European Commission warns about health impact of e-cigarettes
- Tobacco remains the most significant cause of premature death in the EU, responsible for almost 700,000 deaths every year. The EU Tobacco Products Directive introduced new provisions regarding health ...
- European Parliament fights illicit trade of tobacco products
- In the EU, tobacco continues to be the most significant cause of premature deaths responsible for nearly 700,000 deaths every year. One week after the World No Tobacco Day, the European Parliament rat ...
- New air quality legislation approved in Europe
- A deal on the National Emissions Ceilings (NEC) Directive has been reached under the Dutch Presidency of the European Union between the Parliament, the European Commission and the Council of the EU. ...
- Take part in the Commission public consultations for patient-friendly clinical trials
- In the month of June, the European Commission has launched four new public consultations on clinical trials. The consultations are on risk proportionate approaches, on the summary of the clinical tria ...
- eHealth Week: technology for a better life
- The Dutch Ministry of Health together with the European Commission and HIMSS Europe organised from the 8th-10th of June the eHealth Week 2016 and EFA’s Giuseppe De Carlo took part. The event gathered ...
- More investment for prevention – Conclusions of European Health Parliament
- On the 29th June, we participated in the European Health Parliament (EHP) closing session to bring the perspective of allergy, asthma and COPD patients. The European Health Parliament is a platform, ...
- Welcome to Slovakia, new EU Presidency!
- On the 1st of July, Slovakia took over The Netherlands in the rotatory Presidency of the Council of the European Union. For six months, the country will set the EU priorities and lead the discussions. ...